Riskpilot← Back to searchSign inGet full accessDOCTORLINK AS
ASActiveOrg 920560199Sandefjord Helsepark Skiringssalveien 20, 3208 SandefjordGeneral medical practice activities · NACE 8621Est. 201810 employees
Revenue 2024
NOK 7,1M
+2% vs 2023
EBITDA margin
3.4%
-61% vs 2023
Equity ratio
46.9%
Financial strength
Net profit 2024
NOK 152K
-63% vs 2023
| Revenue | NOK 7,1M | +2% |
| EBITDA | NOK 244K | -61% |
| Net profit | NOK 152K | -63% |
| Total assets | NOK 3M | +18% |
| Equity | NOK 1,4M | +12% |
| Employees | 10 | — |
Legal name
DOCTORLINK AS
Org number
920560199
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
7. mars 2018
Share capital
NOK 480 000
Employees
10 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Å utvikle et nettverk for lege- oghelsetjenester av høy kvalitet i norge, og utveksle slike tjenester begge veier over landegrensene. Dette vil omfatte allmennleger, spesialister, operasjoner, spesifikke behandlingstilbud, second opinionvurderinger, medisinsk treningsbehandling, rehabilitering og andre relevante tjenester.
Address
Sandefjord Helsepark Skiringssalveien 20, 3208 Sandefjord
Phone
+4733466300
Email
helpdesk@doctorlink.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 059 | 4 613 | 6 043 | 6 972 | 7 135 |
| Staff expenses | −1 815 | −1 995 | −2 280 | −2 819 | −2 908 |
| EBITDA | 122 | 463 | 566 | 626 | 244 |
| Depreciation & amort. | −92 | −102 | −112 | −96 | −19 |
| EBIT | 29 | 361 | 454 | 530 | 224 |
| Net financials | −0 | −3 | 0 | −2 | −29 |
| Profit before tax | 29 | 358 | 454 | 528 | 195 |
| Tax | 11 | 80 | 109 | 117 | 43 |
| Net profit | 18 | 279 | 345 | 411 | 152 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 722 | 1 339 | 1 848 | 2 573 | 3 036 |
| Equity | 237 | 516 | 861 | 1 272 | 1 424 |
| Long-term debt | 9 | 82 | 56 | 47 | 439 |
| Short-term debt | 476 | 741 | 931 | 1 254 | 1 172 |
| Total debt | 484 | 823 | 987 | 1 301 | 1 612 |
EBITDA margin
3.4%
This company
15.8%
Market median
-78% vs market
20202024
Equity ratio
46.9%
This company
38.2%
Market median
+23% vs market
20202024
Return on equity
10.7%
This company
18.4%
Market median
+42% vs market
20202024
Net profit margin
2.1%
This company
8.1%
Market median
-74% vs market
20202024
Asset turnover
2.35×
This company
1.12×
Market median
+110% vs market
20202024
Debt / equity
1.13×
This company
0.62×
Market median
-82% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HJ Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2019 | |
| Former (2) | ||
| Board of Directors | 2019 – 2024 | |
| Board of Directors | 2019 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 10% | 10% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DOCTORLINK AS 
Hypersensation AsBoard members of DOCTORLINK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Jacob Gravdal | Chief Executive Officer | 0 companies |
| Ragnhild Gravdal | Board of Directors | 0 companies |
| Michael Ballke | Board of Directors | 0 companies |
| Nils Kähler | Board of Directors | 0 companies |